Floatz logo

Procarbazine

Gliomas

Martin-Luther-Universität Halle-WittenbergSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gliomas cohort.

Asset / SponsorPhaseRating
ACETIC ACID, SODIUM SALT (1:1)
Phoenix Molecular Imaging
Phase 2/3B
Cilengitide
Martin-Luther-Universität Halle-Wittenberg
Phase 2CCC
ROSOPATAMAB
Weill Medical College of Cornell University
Phase 1CC
Alloreactive Ctl
Jonsson Comprehensive Cancer Center
Phase 1CC
Fluciclovine
M.D. Anderson Cancer Center
Early Phase 1C

Same molecule, other indications

Procarbazine is also rated in:

central nervous system neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
lymphomaDormant
BB
Indicative ·
69 / 100
View asset →
Adult Giant Cell GlioblastomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →